Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Speck NA, Gilliland DG . Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002; 2: 502–513.

    Article  CAS  PubMed  Google Scholar 

  2. Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32: 148–152.

    Article  CAS  PubMed  Google Scholar 

  3. Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A et al. Natural history of GATA1 mutations in Down syndrome. Blood 2004; 103: 2480–2489.

    Article  CAS  PubMed  Google Scholar 

  4. Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M et al. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 2006; 10: 65–75.

    Article  CAS  PubMed  Google Scholar 

  5. Suzuki M, Abe A, Kiyoi H, Murata M, Ito Y, Shimada K et al. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation. Leukemia 2006; 20: 1168–1169.

    Article  CAS  PubMed  Google Scholar 

  6. Hirose Y, Kudo K, Kiyoi H, Hayashi Y, Naoe T, Kojima S . Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome. Leukemia 2003; 17: 2250–2252.

    Article  CAS  PubMed  Google Scholar 

  7. O'Shea JJ, Husa M, Li D, Hofmann SR, Watford W, Roberts JL et al. Jak3 and the pathogenesis of severe combined immunodeficiency. Mol Immunol 2004; 41: 727–737.

    Article  CAS  PubMed  Google Scholar 

  8. Villeval JL, James C, Pisani DF, Casadevall N, Vainchenker W . New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients. Semin Thromb Hemost 2006; 32: 341–351.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms Manami Kira for secretarial assistance. This work was supported by Grants-in-Aid from the National Institute of Biomedical Innovation, the Ministry of Health, Labor and Welfare and the Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Kiyoi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiyoi, H., Yamaji, S., Kojima, S. et al. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Leukemia 21, 574–576 (2007). https://doi.org/10.1038/sj.leu.2404527

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404527

This article is cited by

Search

Quick links